Geriatric pharmacotherapy, the specialized branch of medicine focused on medication management for elderly individuals, plays a crucial role in addressing the unique healthcare needs of the aging population. As individuals age, physiological changes and the presence of multiple coexisting medical conditions often necessitate careful consideration when prescribing medications. One of the key principles in geriatric pharmacotherapy is tailoring drug regimens to accommodate factors such as renal function, hepatic metabolism, and potential drug interactions. Polypharmacy, the concurrent use of multiple medications, is a common concern in the elderly, requiring vigilant monitoring to prevent adverse drug reactions. Geriatric pharmacotherapy also emphasizes a patient-centered approach, considering factors like cognitive function, mobility, and quality of life. Comprehensive medication reviews and deprescribing efforts are essential to optimize therapeutic outcomes and reduce the risk of medication-related problems. Additionally, healthcare providers must be aware of the Beers Criteria, a list of potentially inappropriate medications for older adults, to guide prescribing decisions. Advancements in technology and telehealth are increasingly being utilized to enhance medication management in elderly populations, promoting adherence and minimizing medication-related issues.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico